25682-007Level 3
KANUMA (Sebelipase alfa)
**Product type:** Human Prescription Drug
**Active ingredient:** SEBELIPASE ALFA
**Strength:** 2 mg/mL
**Dosage form:** Injection, Solution, Concentrate
**Route:** Intravenous
**Labeler:** Alexion Pharmaceuticals, Inc.
**Marketing category:** BLA (BLA125561)
**Pharmacologic class:** Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC], Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC], Sterol Esterase [CS]
GET
/api/v1/systems/ndc_fda/nodes/25682-007Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.